🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
This study consists of two sequential treatment phases. In the first phase,...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2025-05-09
Trial ID
NCT06996132
Treatments Being Tested
The goal of this clinical trial is to test the safety and potential benefit...
Status
Recruiting
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Start Date
2025-09-05
Trial ID
NCT07148791
Treatments Being Tested
Background: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2026-06-16
Trial ID
NCT07328503
Treatments Being Tested
This single-arm, multicenter Phase 2 trial will treat adult patients who ha...
Status
Terminated
Location
University of Alabama Birmingham Comprehensive Cancer Center
Start Date
2015-08-21
Trial ID
NCT02535364
Treatments Being Tested
This is an open label, single-site, dose-escalation study in up to 18 parti...
Status
Recruiting
Location
Hunan Siweikang Therapeutic Co.Ltd
Start Date
2024-04-09
Trial ID
NCT06503224
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of CD1...
Status
Unknown
Location
Children's Hospital of Fudan University
Start Date
2020-01-09
Trial ID
NCT04173988
Treatments Being Tested
Although the anti-CD19 CAR-T cell therapies have gained significant results...
Status
Unknown
Location
Department of Hematology, Xinqiao Hospital
Start Date
2020-12-17
Trial ID
NCT04639739
Treatments Being Tested
Background: -Cluster of differentiation 19 (CD19) and cluster of different...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-12-20
Trial ID
NCT04160195